TY - JOUR
T1 - Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging
T2 - a COSMIC study
AU - Röhr, Susanne
AU - Pabst, Alexander
AU - Riedel-Heller, Steffi G.
AU - Jessen, Frank
AU - Turana, Yuda
AU - Handajani, Yvonne S.
AU - Brayne, Carol
AU - Matthews, Fiona E.
AU - Stephan, Blossom C.M.
AU - Lipton, Richard B.
AU - Katz, Mindy J.
AU - Wang, Cuiling
AU - Guerchet, Maëlenn
AU - Preux, Pierre Marie
AU - Mbelesso, Pascal
AU - Ritchie, Karen
AU - Ancelin, Marie Laure
AU - Carrière, Isabelle
AU - Guaita, Antonio
AU - Davin, Annalisa
AU - Vaccaro, Roberta
AU - Kim, Ki Woong
AU - Han, Ji Won
AU - Suh, Seung Wan
AU - Shahar, Suzana
AU - Din, Normah C.
AU - Vanoh, Divya
AU - van Boxtel, Martin
AU - Köhler, Sebastian
AU - Ganguli, Mary
AU - Jacobsen, Erin P.
AU - Snitz, Beth E.
AU - Anstey, Kaarin J.
AU - Cherbuin, Nicolas
AU - Kumagai, Shuzo
AU - Chen, Sanmei
AU - Narazaki, Kenji
AU - Ng, Tze Pin
AU - Gao, Qi
AU - Gwee, Xinyi
AU - Brodaty, Henry
AU - Kochan, Nicole A.
AU - Trollor, Julian
AU - Lobo, Antonio
AU - López-Antón, Raúl
AU - Santabárbara, Javier
AU - Crawford, John D.
AU - Lipnicki, Darren M.
AU - Sachdev, Perminder S.
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12
Y1 - 2020/12
N2 - Background: Subjective cognitive decline (SCD) is recognized as a risk stage for Alzheimer’s disease (AD) and other dementias, but its prevalence is not well known. We aimed to use uniform criteria to better estimate SCD prevalence across international cohorts. Methods: We combined individual participant data for 16 cohorts from 15 countries (members of the COSMIC consortium) and used qualitative and quantitative (Item Response Theory/IRT) harmonization techniques to estimate SCD prevalence. Results: The sample comprised 39,387 cognitively unimpaired individuals above age 60. The prevalence of SCD across studies was around one quarter with both qualitative harmonization/QH (23.8%, 95%CI = 23.3–24.4%) and IRT (25.6%, 95%CI = 25.1–26.1%); however, prevalence estimates varied largely between studies (QH 6.1%, 95%CI = 5.1–7.0%, to 52.7%, 95%CI = 47.4–58.0%; IRT: 7.8%, 95%CI = 6.8–8.9%, to 52.7%, 95%CI = 47.4–58.0%). Across studies, SCD prevalence was higher in men than women, in lower levels of education, in Asian and Black African people compared to White people, in lower- and middle-income countries compared to high-income countries, and in studies conducted in later decades. Conclusions: SCD is frequent in old age. Having a quarter of older individuals with SCD warrants further investigation of its significance, as a risk stage for AD and other dementias, and of ways to help individuals with SCD who seek medical advice. Moreover, a standardized instrument to measure SCD is needed to overcome the measurement variability currently dominant in the field.
AB - Background: Subjective cognitive decline (SCD) is recognized as a risk stage for Alzheimer’s disease (AD) and other dementias, but its prevalence is not well known. We aimed to use uniform criteria to better estimate SCD prevalence across international cohorts. Methods: We combined individual participant data for 16 cohorts from 15 countries (members of the COSMIC consortium) and used qualitative and quantitative (Item Response Theory/IRT) harmonization techniques to estimate SCD prevalence. Results: The sample comprised 39,387 cognitively unimpaired individuals above age 60. The prevalence of SCD across studies was around one quarter with both qualitative harmonization/QH (23.8%, 95%CI = 23.3–24.4%) and IRT (25.6%, 95%CI = 25.1–26.1%); however, prevalence estimates varied largely between studies (QH 6.1%, 95%CI = 5.1–7.0%, to 52.7%, 95%CI = 47.4–58.0%; IRT: 7.8%, 95%CI = 6.8–8.9%, to 52.7%, 95%CI = 47.4–58.0%). Across studies, SCD prevalence was higher in men than women, in lower levels of education, in Asian and Black African people compared to White people, in lower- and middle-income countries compared to high-income countries, and in studies conducted in later decades. Conclusions: SCD is frequent in old age. Having a quarter of older individuals with SCD warrants further investigation of its significance, as a risk stage for AD and other dementias, and of ways to help individuals with SCD who seek medical advice. Moreover, a standardized instrument to measure SCD is needed to overcome the measurement variability currently dominant in the field.
KW - Cohort study
KW - Data harmonization
KW - Epidemiology
KW - Individual participant data
KW - Prevalence
KW - Subjective cognitive decline
UR - http://www.scopus.com/inward/record.url?scp=85097755164&partnerID=8YFLogxK
U2 - 10.1186/s13195-020-00734-y
DO - 10.1186/s13195-020-00734-y
M3 - Article
SN - 1758-9193
VL - 12
JO - Alzheimer's Research and Therapy
JF - Alzheimer's Research and Therapy
IS - 1
M1 - 167
ER -